EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Lactate dehydrogenase-to-albumin ratio as a novel prognostic biomarker for 28-day mortality in thoracic trauma: a single-center retrospective cohort study ​

Özgür Ömer Yildiz iD, Şükrü Yorulmaz iD, Eray Çinar iD, Hüseyin Mutlu iD, Ramiz Yazici iD, Ayşenur Gür iD, Medine Akkan Öz iD, Bensu Bulut iD, Mustafa Sırrı Kotanoğlu iD, Hakan Güner iD

Turkish Journal of Medical Sciences · 13.08.2026 · 56 (4) · 1141-1151

DOI: 10.55730/1300-0144.6358 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 13.08.2026. Verfasst von Özgür Ömer Yildiz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Ankara Yenimahalle Education and Research Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: L-Lactate Dehydrogenase, Thoracic Injuries, Serum Albumin. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Thoracic trauma accounts for approximately 25% of all trauma-related deaths and remains a significant public health challenge. Early identification of high-risk patients is essential for improving clinical outcomes. The present study evaluates the prognostic value of the lactate dehydrogenase-to-albumin ratio (LDAR) in predicting 28-day mortality in patients with thoracic trauma. Materials and methods: This retrospective observational study was conducted at a Level 1 trauma center between September 2022 and February 2025, and included adult patients presenting with thoracic trauma who underwent thoracic computed tomography. Demographic characteristics, clinical parameters, laboratory values, and 28-day mortality were analyzed. Receiver operating characteristic (ROC) curve analysis was performed to assess the discriminatory power of LDAR and other biomarkers, while multivariate logistic regression was used to identify independent predictors of mortality.

Results

A total of 493 patients were included in the study, 46 of whom (9.3%) died within 28 days. White blood cell count, lactate dehydrogenase, lactate, lactate/albumin ratio, LDAR, and Shock Index were statistically higher in the nonsurvivor group, and albumin, pH, and HCO3 levels were lower (p < 0.001). Furthermore, LDAR was significantly higher in the nonsurvivor group when compared to the survivors (13.51 vs. 7.48, p < 0.001). ROC analysis demonstrated that LDAR had excellent discriminatory power for predicting mortality (AUC = 0.854; 95% CI: 0.795–0.914), with an optimal cutoff value of 11.56 yielding 71.7% sensitivity and 91.5% specificity.

Conclusion

LDAR is a reliable and independent prognostic biomarker for predicting in-hospital mortality in patients with thoracic trauma. As a ratio derived from routine laboratory parameters without additional cost, LDAR offers a practical tool for rapid risk stratification and triage optimization in emergency settings. Prospective multicenter studies are warranted to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

L-Lactate DehydrogenaseThoracic InjuriesSerum AlbuminHumansRetrospective StudiesBiomarkersFemalePrognosisMaleMiddle AgedAdultROC CurveAged

Stichwörter der Autor:innen

LDARThoracic traumabiomarkeremergency medicinemortality prediction

Substanzen

BiomarkersL-Lactate DehydrogenaseSerum Albumin

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Ankara Yenimahalle Education and Research Hospital, Ankara, Turkiye.
  • Department of Emergency Medicine, Ankara Health Practice and Research Center, University of Health Sciences, Ankara, Turkiye.
  • Department of Thoracic Surgery, Ankara Bilkent City Hospital, Ankara, Turkiye.
  • Department of Emergency Medicine, Faculty of Medicine, Aksaray University, Aksaray, Turkiye.
  • Department of Emergency Medicine, Kanuni Sultan Süleyman Education and Research Hospital, University of Health Sciences, İstanbul, Turkiye.
  • Department of Emergency Medicine, Etimesgut Şehit Sait Ertürk State Hospital, Ankara, Turkiye.

ORCID-Profile: Özgür Ömer Yildiz, Şükrü Yorulmaz, Eray Çinar, Hüseyin Mutlu, Ramiz Yazici, Ayşenur Gür, Medine Akkan Öz, Bensu Bulut, Mustafa Sırrı Kotanoğlu, Hakan Güner

Zitieren

APA

Yildiz, Ö. Ö., Yorulmaz, Ş., Çinar, E., Mutlu, H., Yazici, R., Gür, A., Akkan Öz, M., Bulut, B., Kotanoğlu, M. S., & Güner, H. (2026). Lactate dehydrogenase-to-albumin ratio as a novel prognostic biomarker for 28-day mortality in thoracic trauma: a single-center retrospective cohort study ​. Turkish Journal of Medical Sciences, 56(4), 1141-1151. https://doi.org/10.55730/1300-0144.6358

Vancouver

Yildiz ÖÖ, Yorulmaz Ş, Çinar E, Mutlu H, Yazici R, Gür A, et al. Lactate dehydrogenase-to-albumin ratio as a novel prognostic biomarker for 28-day mortality in thoracic trauma: a single-center retrospective cohort study ​. Turkish Journal of Medical Sciences. 2026;56(4):1141-1151. doi:10.55730/1300-0144.6358

BibTeX
@article{Yildiz2026,
  author = {Yildiz, Özgür Ömer and Yorulmaz, Şükrü and Çinar, Eray and Mutlu, Hüseyin and Yazici, Ramiz and Gür, Ayşenur and Akkan Öz, Medine and Bulut, Bensu and Kotanoğlu, Mustafa Sırrı and Güner, Hakan},
  title = {Lactate dehydrogenase-to-albumin ratio as a novel prognostic biomarker for 28-day mortality in thoracic trauma: a single-center retrospective cohort study ​},
  journal = {Turkish Journal of Medical Sciences},
  year = {2026},
  volume = {56},
  number = {4},
  pages = {1141--1151},
  doi = {10.55730/1300-0144.6358}
}
Kostenlos starten →